ABIVAX Société Anonyme (EPA:ABVX)
81.10
-1.70 (-2.05%)
Oct 16, 2025, 5:35 PM CET
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of €6.26 billion as of October 16, 2025. Its market cap has increased by 1,037.87% in one year.
Market Cap
6.26B
Enterprise Value
6.30B
Revenue
6.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
€81.10
Market Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from 202.12M to 6.26B, an increase of 2,995.89%. That is a compound annual growth rate of 39.50%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 15, 2025 | 6.26B | 1,361.50% |
Dec 31, 2024 | 428.15M | -30.40% |
Dec 29, 2023 | 615.18M | 493.46% |
Dec 30, 2022 | 103.66M | -77.81% |
Dec 31, 2021 | 467.16M | -1.83% |
Dec 31, 2020 | 475.89M | 79.43% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
EssilorLuxottica Société anonyme | 125.53B |
Sanofi | 102.14B |
Sartorius Stedim Biotech | 17.79B |
bioMérieux | 12.81B |
Eurofins Scientific SE | 11.00B |
Ipsen | 9.36B |
Virbac | 2.58B |
emeis Société anonyme | 2.47B |